Investigating how a specific receptor in brain immune cells affects epilepsy development
Microglial P2Y6 receptor calcium signaling as a core regulator of epileptogenesis
This study is looking at how certain brain cells respond during seizures and help clean up after them, which could lead to new ways to treat epilepsy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10973729 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of microglial P2Y6 receptor calcium signaling in the development of epilepsy. By using advanced imaging techniques, the study will observe how these immune cells in the brain respond during and after seizures, particularly looking at their ability to clear dead neurons. The researchers will employ a unique mouse model that allows for real-time observation of microglial activity, providing insights into their function during epileptogenesis. The findings could help clarify the mechanisms behind epilepsy and identify potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a history of seizures or those at risk of developing epilepsy.
Not a fit: Patients who do not have any neurological conditions or seizures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent or mitigate epilepsy by targeting specific cellular processes.
How similar studies have performed: While the specific focus on P2Y6 receptor signaling in epilepsy is relatively novel, similar approaches have shown promise in understanding other neurological conditions.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Umpierre, Anthony David — University of Minnesota
- Study coordinator: Umpierre, Anthony David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.